First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine

This study, which is the fruit of collaborative work by scientists at stem cell banks and cellular information registries worldwide, including those in the U.S., the U.K., Europe, and Japan, proposes new minimum information guidelines, Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), for cellular assay data deposition. MIACARM is intended to promote data exchange and facilitation of practical regenerative medicine.
Source: Stem Cells Translational Medicine - Category: Stem Cells Authors: Tags: Mesenchymal Stem Cells, Standards, Policies, Protocols, and Regulations for Cell-Based Therapies Source Type: research